BARBARA SAMUELS, M.D.

M.D.

Developmental - Behavioral Pediatrics Physician

NPI: 1053445130Individual

Specialties, Licenses & Credentials

Developmental - Behavioral Pediatrics PhysicianPrimary

Pediatrics — Developmental - Behavioral Pediatrics

Code: 2080P0006X

222757-1(NY)27514(NC)MD-13092(HI)18197(NH)

Research & Publications (20)

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.

PMID 19168784·Blood·2009

8-other

Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

PMID 19451433·J Clin Oncol·2009

3-trial

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

PMID 19477151·Neuron·2009

7-preclinical

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

PMID 19652065·J Clin Oncol·2009

3-trial

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

PMID 18564354·Br J Haematol·2008

8-other

Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.

PMID 18348295·Cancer·2008

3-trial

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.

PMID 18927308·Clin Cancer Res·2008

3-trial

Ndel1 controls the dynein-mediated transport of vimentin during neurite outgrowth.

PMID 18303022·J Biol Chem·2008

7-preclinical

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

PMID 18411419·Blood·2008

3-trial

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.

PMID 17456058·Br J Haematol·2007

3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address: 275 MAMMOTH RD STE 1
MANCHESTER, NH 03109
Phone: (036) 663-8285

Quick Facts

NPI: 1053445130
Entity Type: Individual
Gender: Female
Medicare: Not confirmed
Specialties: 4
Locations: 1
Publications: 20

Are you this provider?

Claim Your Profile